CONMED Corporation (NYSE: CNMD) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 24.52 | EPS (ttm) | 1.85 | Insider Own | 2.98% | Shs Outstand | 29.95M | Perf Week | -1.90% |
| Market Cap | 1.36B | Forward P/E | 9.50 | EPS next Y | 4.78 | Insider Trans | 0.00% | Shs Float | 29.82M | Perf Month | -11.38% |
| Enterprise Value | 2.16B | PEG | - | EPS next Q | 1.00 | Inst Own | - | Short Float | 7.59% | Perf Quarter | 39.41% |
| Income | 56.32M | P/S | 0.99 | EPS this Y | 145.17% | Inst Trans | - | Short Ratio | 3.76 | Perf Half Y | 23.42% |
| Sales | 1.37B | P/B | 1.31 | EPS next Y | 5.42% | ROA | 2.46% | Short Interest | 2.26M | Perf YTD | 11.87% |
| Book/sh | - | P/C | 9.07 | EPS next 5Y | 10.44% | ROE | 5.51% | 52W High | 53.66 -15.36% | Perf Year | -10.02% |
| Cash/sh | - | P/FCF | 10.12 | EPS past 3/5Y | - 36.38% | ROIC | 4.97% | 52W Low | 31.44 44.47% | Perf 3Y | -57.74% |
| Dividend Est. | 0.80 (1.76%) | EV/EBITDA | 11.99 | Sales past 3/5Y | 9.55% 9.77% | Gross Margin | 54.80% | Volatility | 2.80% 2.98% | Perf 5Y | -63.06% |
| Dividend TTM | 0.20 (0.44%) | EV/Sales | 1.57 | EPS Y/Y TTM | -56.57% | Oper. Margin | 10.79% | ATR (14) | 1.59 | Perf 10Y | 7.91% |
| Dividend Ex-Date | Sep 15, 2025 | Quick Ratio | 0.69 | Sales Y/Y TTM | 4.97% | Profit Margin | 4.12% | RSI (14) | 37.17 | Recom | 2.71 |
| Dividend Gr. 3/5Y | -9.14% -5.59% | Current Ratio | 1.48 | EPS Q/Q | 20.00% | SMA20 | -6.31% | Beta | 0.95 | Target Price | 37.50 |
| Payout | 21.91% | Debt/Eq | 0.80 | Sales Q/Q | 0.00% | SMA50 | -3.73% | Rel Volume | 1.44 | Prev Close | 46.13 |
| Employees | 3,900 | LT Debt/Eq | 0.81 | Earnings | Nov 04 | SMA200 | 11.67% | Avg Volume | 540.93K | Price | 45.42 |
| IPO Date | Jul 23, 1987 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 24.32% 1.75% | Net Debt/EBITDA | 4.43 | Volume | 780,477 | Change | -1.54% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-13-26 | Reiterated | Wells Fargo | Equal Weight | $39 |
| Jul-08-26 | Initiated | BMO Capital | Market Perform | $36 |
| Jun-29-26 | Downgrade | B of A Securities | Neutral → Underperform | |
| Mar-17-26 | Downgrade | Piper Sandler | Overweight → Neutral | |
| Jun-12-25 | Downgrade | Needham | Buy → Hold | |
| May-01-25 | Reiterated | Needham | Buy | $97 → $61 |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold | |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral | |
| Oct-04-24 | Reiterated | Needham | Buy | $107 → $97 |
| Apr-25-24 | Reiterated | Needham | Buy | $107 |
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,372 | 1,374 | 1,307 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 621 | 649 | 574 | — | — | — | — | — | — | |
| Gross Profit | 751 | 725 | 733 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 545 | 528 | 478 | — | — | — | — | — | — | |
| Research and Development | 61 | 56 | 54 | — | — | — | — | — | — | |
| Other Operating Expense | -2 | 0 | 1 | — | — | — | — | — | — | |
| Operating Income | 147 | 141 | 200 | — | — | — | — | — | — | |
| Interest Expense | 30 | 31 | 37 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -35 | -39 | 0 | — | — | — | — | — | — | |
| Net Income Before Taxes | 82 | 71 | 163 | — | — | — | — | — | — | |
| Income Taxes | 27 | 24 | 31 | — | — | — | — | — | — | |
| Consolidated Net Income | 57 | 47 | 132 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 57 | 47 | 132 | — | — | — | — | — | — | |
| Net Income | 57 | 47 | 132 | — | — | — | — | — | — | |
| EPS (Recurring) | 1.85 | 1.52 | 4.29 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.85 | 1.52 | 4.29 | — | — | — | — | — | — | |
| EPS (Diluted) | 1.85 | 1.51 | 4.26 | — | — | — | — | — | — | |
| EBITDA | 179 | 155 | 272 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 24.55 | 26.89 | 16.07 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.99 | 0.92 | 1.62 | — | — | — | — | — | — | |
| Gross Margin | 54.74 | 52.77 | 56.08 | — | — | — | — | — | — | |
| Operating Margin | 10.71 | 10.26 | 15.30 | — | — | — | — | — | — | |
| Net Margin | 4.15 | 3.42 | 10.10 | — | — | — | — | — | — | |
| Shares Outstanding | 30 | 31 | 31 | — | — | — | — | — | — | |
| Market Capitalization | 1,363 | 1,259 | 2,122 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Kelderman Kim | Director | Sep 08 '26 | Option Exercise | 0.00 | 500 | 0 | 500 | Sep 10 |
| Lalomia Brent | Executive VP RA, QA | Mar 06 '26 | Option Exercise | 0.00 | 75 | 0 | 941 | Mar 10 |
| Kaye Mark | Director | Feb 24 '26 | Option Exercise | 0.00 | 152 | 0 | 152 | Feb 26 |
| Glaze Richard | Chief Information Officer | Nov 21 '25 | Sale | 41.21 | 257 | 10,591 | 0 | Nov 24 |
| Glaze Richard | Chief Information Officer | Nov 20 '25 | Option Exercise | 0.00 | 375 | 0 | 375 | Nov 21 |
| Garner Todd W | Executive Vice President & CFO | Nov 06 '25 | Sale | 43.00 | 3,500 | 150,500 | 1,836 | Nov 07 |
| Foust Hollie K | General Counsel & Corp Sec | Nov 04 '25 | Option Exercise | 0.00 | 4,000 | 0 | 4,000 | Nov 05 |
| Garner Todd W | Executive Vice President & CFO | Oct 31 '25 | Option Exercise | 0.00 | 7,500 | 0 | 7,500 | Nov 03 |
| Farkas Charles | Director | Sep 12 '25 | Sale | 53.52 | 2,000 | 107,049 | 14,859 | Sep 15 |
| Garner Todd W | Executive Vice President & CFO | Aug 07 '25 | Sale | 52.45 | 598 | 31,365 | 0 | Aug 08 |
| Bronson David M. | Director | Jun 03 '25 | Option Exercise | 0.00 | 479 | 0 | 17,241 | Jun 04 |
| Concannon Brian | Director | Jun 03 '25 | Option Exercise | 0.00 | 479 | 0 | 10,116 | Jun 04 |
| Schwarzentraub Barbara J | Director | Jun 03 '25 | Option Exercise | 0.00 | 479 | 0 | 4,344 | Jun 04 |
| Aronson Martha Goldberg | Director | Jun 03 '25 | Option Exercise | 0.00 | 479 | 0 | 12,391 | Jun 04 |
| Council LaVerne H | Director | Jun 03 '25 | Option Exercise | 0.00 | 479 | 0 | 4,048 | Jun 04 |